Natural Product Sciences

  • 제14권2호
  • /
  • Pages.143-146
  • /
  • 2008
  • /
  • 1226-3907(pISSN)
  • /
  • 2288-9027(eISSN)
한국생약학회 (The Korean Society of Pharmacognosy)
권호 표지

Protein Tyrosine Phosphatase 1B inhibitory Activity of Anthraquinones and Stilbenes

  • Na, Min-Kyun (College of Pharmacy, Yeungnam University) ;
  • Jin, Wen Yi (College of Pharmacy, Chungnam National University) ;
  • Min, Byung-Sun (College of Pharmacy, Catholic University of Daegu) ;
  • Ahn, Jong-Seog (Korea Research Institute of Bioscience and Biotechnology (KRIBB),) ;
  • Bae, Ki-Hwan (College of Pharmacy, Chungnam National University)
  • 발행 : 2008.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Protein tyrosine phosphatase 1B (PTP1B) is emerging as a potential therapeutic target for the treatment of type-2 diabetes and obesity. To search for new types of PTP1B inhibitors, we have undertaken in vitro enzyme assay for some anthraquinones and stilbenes isolated from plants. Of the anthraquinones tested, physcion (1), 1-O-methylemodin (2), and emodin (3) showed high activities, with $IC_{50}$ values of 7.6, 7.0, and $3.8{\mu}g/mL$, respectively, while the anthraquinone glycosides, physcion-8-O-${\beta}$-D-glucopyranoside (4) and emodin-8- O-${\beta}$-D-glucopyranoside (5), were less active than their aglycones. All the stilbenens (6 - 15) slightly inhibited PTP1B activity at high concentration of $30{\mu}g/mL$. Our findings suggest that the hypoglycemic effect of anthraquinones may be associated with their PTP1B inhibitory activity.

키워드

참고문헌

  1. Bialy, L. and Waldmann, H., Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew. Chem. Int. Ed. 44, 3814-3839 (2005) https://doi.org/10.1002/anie.200461517
  2. Choi, S.Z., Lee, S.O., Jang, K.U., Chung, S.H., Park, S.H., Kang, H.C., Yang, E.Y., Cho, H.J., and Lee, K.R., Antidiabetic stilbene and anthraquinone derivatieves from Rheum undulatum. Arch. Pharm. Res. 28, 1027-1030 (2005) https://doi.org/10.1007/BF02977396
  3. Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A.L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.C., Ramachandran, C., Gresser, M.J., Tremblay, M.L., and Kennedy, B.P., Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548 (1999) https://doi.org/10.1126/science.283.5407.1544
  4. Huang, Q., Lu, G., Shen, H.M., Chung, M.C.M., and Ong, C.N., Anticancer properties of anthraquinones from Rhubarb. Med. Res. Rev. 27, 609-630 (2003) https://doi.org/10.1002/med.20094
  5. Issad, T., Boute, N., Boubekeur, S., Lacasa, D., and Pernet, K., Looking for an insulin pill? Use the BRET methodology! Diabetes Metab. 29, 111-117 (2003) https://doi.org/10.1016/S1262-3636(07)70016-2
  6. Jin, W.Y, Na, M., Song, G.Y., Lee, Y.M., and Bae, K., Cytotoxic anthraquinones and stilbenes from Reynoutria sachaliensis Nakai. Kor. J. Med. Crop Sci. 13, 80-84 (2005)
  7. Johnson, T.O., Ermolieff, J., and Jirousek, M.R., Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat. Rev. Drug Discov. 1, 696-709 (2002) https://doi.org/10.1038/nrd895
  8. Kenner, K.A., Anyanwu, E., Olefsky, J.M., and Kusari, J., Proteintyrosine phosphatase 1B is a negative regulator of insulin- and insulinlike growth factor-I-stimulated signaling. J. Biol. Chem. 271, 19810-19816 (1996) https://doi.org/10.1074/jbc.271.33.19810
  9. Li, S., An, T.Y., Li, J., Shen, Q., Lou, F.C., and Hu, L.H., PTP1B inhibitors from Saussrurea lappa. J. Asian Nat. Prod. Res. 8, 281-286 (2006) https://doi.org/10.1080/10286020412331286434
  10. Na, M., Min, B.S., and Bae, K., Protective effect of stilbenes on oxidative damage. Nat. Prod. Sci. 13, 369-372 (2007a)
  11. Na, M., Hoang, D.M., Njamen, D., Mbafor, J.T., Fomum, Z.T., Thuong, P.T., Ahn, J.S., and Oh, W.K., Inhibitory effect of 2-arylbenzofurans from Erythrina addisoniae on protein tyrosine phosphatase-1B. Bioorg. Med. Chem. Lett. 17, 3868-3871 (2007b) https://doi.org/10.1016/j.bmcl.2007.05.005
  12. Taylor, S.D. and Hill, B., 2004. Recent advances in protein tyrosine phosphatase 1B inhibitors. Expert Opin. Investig. Drugs 13, 199-214 https://doi.org/10.1517/13543784.13.3.199